Table 4 Distribution of clinical parameters of participants in different tertiles based on serum concentrations of asprosin in all subjects
From: Serum concentration of asprosin in new-onset type 2 diabetes
Variable | T1 | T2 | T3 | P-value |
|---|---|---|---|---|
Asprosin (ng/mL) | 2.18 (0.4) | 3.65 (1.58) | 8.04 (1.74) | < 0.001 |
Age (year) | 53 (13) | 52 (8) | 53 (8) | 0.822 |
BMI (kg/m2) | 25.79 (1.82) | 26.75 (3) | 28.38 (2.98) | < 0.001 |
FBG (mg/dL) | 83.5 (15) | 100 (36) | 209 (83) | < 0.001 |
Insulin (mIU/L) | 7.7 (5.01) | 7.5 (5.45) | 10.55 (4.18) | < 0.001 |
HbA1c (%) | 5.50 (0.7) | 5.73 (1.72) | 8.99 (2.09) | < 0.001 |
TC (mg/dL) | 198.5 (61) | 194 (63) | 197 (41) | 0.403 |
TAG (mg/dL) | 136 (87) | 153 (79) | 223 (145) | < 0.001 |
HDL-C (mg/dL) | 42.5 (18) | 43 (15) | 52 (17) | < 0.001 |
LDL-C (mg/dL) | 124.5 (49) | 125 (56) | 96 (21) | 0.002 |
LDL-C/HDL-C | 3.11 (1.69) | 2.85 (1.74) | 2.04 (0.4) | < 0.001 |
TC/HDL-C | 4.65 (2.06) | 4.19 (1.43) | 3.98 (0.64) | 0.052 |
TAG/HDL-C | 3.56 (2.26) | 3.52 (1.74) | 4.41 (3.85) | 0.041 |
HOMA-IR | 0.99 (0.76) | 0.99 (0.86) | 1.83 (0.75) | < 0.001 |
HOMA-β | 87 (54.92) | 64.85 (32.32) | 25.4 (19.50) | < 0.001 |
HOMA-S | 99.85 (93.12) | 101.2 (97.85) | 54.60 (20.75) | < 0.001 |
QUICKI | 0.36 (0.05) | 0.35 (0.06) | 0.29 (0.01) | < 0.001 |